Lipoprotein(a): cardiovascular risk and emerging therapies
Author:
Affiliation:
1. Victorian Heart Institute, Monash University, Melbourne, Australia
2. Monash Cardiovascular Research Centre, Monash University, Clayton, Australia
Funder
funded
Publisher
Informa UK Limited
Subject
Cardiology and Cardiovascular Medicine,General Medicine,Internal Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/14779072.2023.2197593
Reference90 articles.
1. Lipoprotein Lp(a) and the risk for myocardial infarction
2. Clinical Factors Associated With Calcific Aortic Valve Disease fn1fn1This study was supported in part by Contracts NO1-HC85079 through HC-850086 from the National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.
3. The effect of LPA Thr3888Pro on lipoprotein(a) and coronary artery disease is modified by the LPA KIV-2 variant 4925G>A
4. Lipoprotein(a) in hereditary hypercholesterolemia: Influence of the genetic cause, defective gene and type of mutation
5. Single Ascending Dose Study of a Short Interfering RNA Targeting Lipoprotein(a) Production in Individuals With Elevated Plasma Lipoprotein(a) Levels
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Ignored or underestimated - Evaluation and treatment of cardiovascular risk factors in patients with adrenal insufficiency Undertreatment of cardiovascular risk factors in patients with adrenal insufficiency;2024-09-12
2. The Mechanisms of PCSK9 Inhibitor Reducing Lipoprotein(a);PROG BIOCHEM BIOPHYS;2024
3. Carbon-based light addressable potential sensor based on nitrogen-doped graphene quantum dots for detection of low-density lipoprotein;Microchemical Journal;2024-01
4. Biology of time: The temporal distance between cause and effect;Alzheimer' s Disease Research Guide;2024
5. Perspectives on the success of plasma lipidomics in cardiovascular drug discovery and future challenges;Expert Opinion on Drug Discovery;2023-12-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3